NFKB1 and neoplasm: The activation of the STING pathway induces anti-tumor immune responses by activating multiple pathways, including IRF3 and NF-κB [12,13], and then remodeling the inhibitory TME and the sensitizing the ICI by regulating the level of other immune and inflammatory factors.